跳至主要内容
临床试验/NCT02369497
NCT02369497终止不适用

Ascension® Humeral Resurfacing Arthroplasty HRA Follow-Up Study

Integra LifeSciences Corporation1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2007年12月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
59
试验地点
1
主要终点
American Shoulder and Elbow Surgeons (ASES) Score

研究概览

简要总结

This is a prospective study on the Ascension HRA device to collect data to assess the safety and effectiveness of the HRA.

详细描述

This study protocol will provide guidance to investigators wanting to perform a non-randomized, consecutive enrollment, 10-year follow-up study of patients who are treated with the Ascension® HRA. Its purpose is to measure and document the outcomes associated with implanting the Ascension HRA prosthesis. Patients will be periodically assessed to collect data related to safety and effectiveness endpoints at the following intervals: preoperative, surgery/immediate post-op, 3 months, 6 months, 1 year, 2 year, 5 year, and 10 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient who is to be treated with the Ascension HRA is eligible for inclusion in this study. Therefore, Principal Investigators should attempt to recruit all patients at the study site who are treated with the Ascension HRA
  • The following patient will be included in the study - Patient who:
  • Is treated with the Ascension HRA
  • Is disabled by either non-inflammatory or inflammatory arthritis (i.e. rheumatoid arthritis, osteoarthritis and avascular necrosis
  • Has mild or moderate humeral head deformity and /or limited motion
  • Has post-traumatic arthritis
  • Has an intact or reparable rotator cuff
  • Has the means and ability to return for all required study visits
  • Is willing to participate in the study
  • Has signed an Informed Consent Form
  • Is at least 18 years of age and skeletally mature at the time of surgery
  • Is less than 75 years of age at the time of surgery

排除标准

  • Infection, sepsis, and osteomyelitis
  • Osteoporosis
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Rapid joint destruction, marked bone loss or bone resorption apparent on X-ray
  • Revision procedures where other devices or treatments have failed
  • Refuses to be in the study; or does not have the means and ability to return for all required study visits
  • Currently participating in another clinical study

结局指标

主要结局

American Shoulder and Elbow Surgeons (ASES) Score

时间窗: 2 years

The American Shoulder and Elbow Score is a functional outcome tool that has been validated for various shoulder conditions

次要结局

  • Visual Analog Scale for pain(2 years)
  • X-rays(2 years)
  • Adverse events(Surgery; 3 month, 6 month, 1 year and 2 years post-op)
  • Range of Motion(2 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ascension® Humeral Resurfacing Arthroplasty (HRA)... | 临床试验